Neuberger Berman Group LLC Acquires 1,211,743 Shares of Henry Schein, Inc. (HSIC)
Neuberger Berman Group LLC grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 95.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,475,058 shares of the company’s stock after purchasing an additional 1,211,743 shares during the period. Neuberger Berman Group LLC owned about 1.58% of Henry Schein worth $202,930,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. California Public Employees Retirement System increased its stake in shares of Henry Schein by 111.6% during the third quarter. California Public Employees Retirement System now owns 445,878 shares of the company’s stock worth $36,558,000 after buying an additional 235,153 shares during the period. Janney Montgomery Scott LLC increased its stake in shares of Henry Schein by 31.3% during the third quarter. Janney Montgomery Scott LLC now owns 3,146 shares of the company’s stock worth $258,000 after buying an additional 750 shares during the period. Bamco Inc. NY increased its stake in shares of Henry Schein by 84.7% during the third quarter. Bamco Inc. NY now owns 665,430 shares of the company’s stock worth $54,559,000 after buying an additional 305,235 shares during the period. Carderock Capital Management Inc. increased its stake in shares of Henry Schein by 98.7% during the third quarter. Carderock Capital Management Inc. now owns 54,197 shares of the company’s stock worth $4,444,000 after buying an additional 26,916 shares during the period. Finally, Cubist Systematic Strategies LLC increased its stake in shares of Henry Schein by 365.5% during the third quarter. Cubist Systematic Strategies LLC now owns 11,596 shares of the company’s stock worth $951,000 after buying an additional 9,105 shares during the period. Institutional investors own 91.75% of the company’s stock.
A number of research firms recently weighed in on HSIC. Royal Bank of Canada cut their target price on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating on the stock in a research note on Tuesday, November 7th. Jefferies Group reaffirmed a “hold” rating and issued a $89.00 price target on shares of Henry Schein in a report on Friday, October 20th. Credit Suisse Group reaffirmed a “hold” rating and issued a $87.50 price target on shares of Henry Schein in a report on Tuesday, August 29th. Stephens began coverage on Henry Schein in a report on Tuesday, November 28th. They issued an “equal weight” rating and a $76.00 price target for the company. Finally, Morgan Stanley downgraded Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 price target for the company. in a report on Wednesday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the stock. Henry Schein has an average rating of “Hold” and an average price target of $87.79.
In other news, Director Barry J. Alperin sold 5,796 shares of the stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $70.76, for a total value of $410,124.96. Following the completion of the sale, the director now directly owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.19% of the stock is currently owned by corporate insiders.
Henry Schein, Inc. (HSIC) opened at $67.81 on Wednesday. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $10,700.00, a P/E ratio of 19.05, a P/E/G ratio of 1.91 and a beta of 0.99. Henry Schein, Inc. has a fifty-two week low of $65.28 and a fifty-two week high of $93.50.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). The business had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period last year, the company earned $0.84 earnings per share. equities analysts anticipate that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year.
Henry Schein announced that its board has authorized a stock buyback plan on Monday, September 18th that permits the company to repurchase $400.00 million in shares. This repurchase authorization permits the company to purchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.
TRADEMARK VIOLATION WARNING: “Neuberger Berman Group LLC Acquires 1,211,743 Shares of Henry Schein, Inc. (HSIC)” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.watchlistnews.com/neuberger-berman-group-llc-acquires-1211743-shares-of-henry-schein-inc-hsic/1760585.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with Analyst Ratings Network's FREE daily email newsletter.